sabine GERBAL-CHALOIN

Dr. sabine GERBAL-CHALOIN

INSERM U183
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Biochimica et Biophysica Acta (BBA) - General Subjects
Verified
Journal Article
Closed access
JPJ.M. Pascussi
J.M. Pascussi
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
LDL. Drocourt
L. Drocourt
PMP. Maurel
P. Maurel
MVM.J. Vilarem
M.J. Vilarem

1 February 2008 in Annual Review of Pharmacology and Toxicology
Verified
Journal Article
Closed access
JPJean-Marc Pascussi
Jean-Marc Pascussi
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
CDCédric Duret
Cédric Duret
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
MVMarie-José Vilarem
Marie-José Vilarem
PMPatrick Maurel
Patrick Maurel
The expression of many genes involved in xenobiotic/drug metabolism and transport is regulated by at least three nuclear receptors or xenosensors: aryl hydrocarbon receptor (AhR), constitutive androstane receptor (CAR), and pregnane X receptor (PXR). These receptors establish crosstalk with other nuclear receptors or transcription factors controlling signaling pathways that regulate the homeostasis of bile acids, lipids, glucose, inflammation, vitamins, hormones, and others. These crosstalks are expected to modify profoundly our vision of xenobiotic/drug disposition and toxicity. They provide molecular mechanisms to explain how physiopathological stimuli affect xenobiotic/drug disposition, and how xenobiotics/drugs may affect physiological functions and generate toxic responses. In addition, the possibility that xenosensors may control other signaling pathways opens the way to new pharmacological opportunities.

15 December 2001 in European Journal of Biochemistry
Verified
Journal Article
Open access
PDF file
JPJean‐Marc Pascussi
Jean‐Marc Pascussi
LDLionel Drocourt
Lionel Drocourt
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
JFJean‐Michel Fabre
Jean‐Michel Fabre
PMPatrick Maurel
Patrick Maurel
MVMarie‐José Vilarem
Marie‐José Vilarem
Although CYP3A induction by dexamethasone has been extensively documented, its mechanism is still unclear because both the role of the glucocorticoid receptor and the ability of dexamethasone to activate the human pregnane X receptor have been questioned. In an attempt to resolve this problem, we investigated the response of CYP3A4 to dexamethasone (10 nm–100 µm) in primary human hepatocytes and HepG2 cells, using a variety of methods: kinetic analysis of CYP3A4 and tyrosine aminotransferase expression, effects of RU486 and cycloheximide, ligand binding assay, cotransfection of HepG2 cells with CYP3A4 reporter gene constructs and vectors expressing the glucocorticoid receptor, pregnane X receptor or constitutively activated receptor. In contrast to rifampicin (monophasic induction), dexamethasone produces a biphasic induction of CYP3A4 mRNA consisting of a low‐dexamethasone component (nmol concentrations) of low amplitude (factor of 3–4) followed by a high‐dexamethasone component (supramicromolar concentrations) of high amplitude (factor of 15–30). We show that the low‐dexamethasone component results from the glucocorticoid receptor‐mediated expression of pregnane X receptor and/or constitutively activated receptor which, in turn, are able to transactivate CYP3A4 in a xenobiotic‐independent manner. At supramicromolar concentrations (>10 µm), dexamethasone binds to and activates pregnane X receptor thus producing the high‐dexamethasone component of CYP3A4 induction. We conclude that, in contrast to the other xenobiotic inducers of CYP3A4, glucocorticoids play a dual role in CYP3A4 expression, first by controlling the expression of PXR and CAR under physiological conditions (submicromolar concentrations) through the classical glucocorticoid receptor pathway, and second by activating the pregnane X receptor under bolus or stress conditions (supramicromolar concentrations).

1 January 2002 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
JPJean-Marc Pascussi
Jean-Marc Pascussi
LPLydiane Pichard-Garcia
Lydiane Pichard-Garcia
MVMarie-Jose Vilarem
Marie-Jose Vilarem
PMPatrick Maurel
Patrick Maurel
Although cytochrome P450 2C9 (CYP2C9) is a major CYP expressed in the adult human liver, its mechanism of regulation is poorly known. In previous work, we have shown that CYP2C9is inducible in primary human hepatocytes by xenobiotics including dexamethasone, rifampicin, and phenobarbital. The aim of this work was to investigate the molecular mechanism(s) controlling the inducible expression of CYP2C9. Deletional analysis ofCYP2C9 regulatory region (+21 to −2088) in the presence of various hormone nuclear receptors suggested the presence of two functional response elements, a glucocorticoid receptor-responsive element (−1648/−1684) and a constitutive androstane receptor-responsive element (CAR, −1783/−1856). Each of these were characterized by co-transfection experiments, directed mutagenesis, gel shift assays, and response to specific antagonists RU486 and androstanol. By these experiments we located a glucocorticoid-responsive element imperfect palindrome at −1662/−1676, and a DR4 motif at −1803/−1818 recognized and transactivated by human glucocorticoid receptor and by hCAR and pregnane X receptor, respectively. Identification of these functional elements provides rational mechanistic basis for CYP2C9induction by dexamethasone (submicromolar concentrations), and by phenobarbital and rifampicin, respectively. CYP2C9 appears therefore to be a primary glucocorticoid-responsive gene, which in addition, may be induced by xenobiotics through CAR/pregnane X receptor activation.

1 December 2000 in Molecular Pharmacology
Verified
Journal Article
Closed access
JPJean-Marc Pascussi
Jean-Marc Pascussi
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
JFJean-Michel Fabre
Jean-Michel Fabre
PMPatrick Maurel
Patrick Maurel
MVMarie-José Vilarem
Marie-José Vilarem
The barbiturate phenobarbital induces the transcription of cytochromes P450 (CYPs) 2B through the constitutive androstane receptor (CAR; NR1I3). CAR is a member of the nuclear receptor family (NR1) mostly expressed in the liver, which heterodimerizes with retinoid X receptor (RXR) and was shown to transactivate both the phenobarbital responsive element module of the human CYP2B6 gene and the CYP3A4 xenobiotic response element. Because previous studies in rodent hepatocyte cultures have shown that the phenobarbital-mediated induction of CYP2B genes is potentiated by glucocorticoids, we examined the role of activated glucocorticoid receptor in this process. We show that submicromolar concentrations of dexamethasone enhance phenobarbital-mediated induction of CYP3A4, CYP2B6, and CYP2C8 mRNA in cultured human hepatocytes. In parallel, we observed that glucocorticoid agonists, such as dexamethasone, prednisolone, or hydrocortisone, specifically increase human car (hCAR) mRNA expression. Accumulation of hCAR mRNA parallels that of tyrosine aminotransferase: both mRNAs reach a maximum at a concentration of 100 nM dexamethasone and are down-regulated by concomitant treatment with the glucocorticoid antagonist RU486. Moreover, the effect of dexamethasone on hCAR mRNA accumulation appears to be of transcriptional origin because the addition of protein synthesis inhibitor cycloheximide has no effect, and dexamethasone does not affect the degradation of hCAR mRNA. Furthermore, dexamethasone increases both basal and phenobarbital-mediated nuclear translocation of CAR immunoreactive protein in human hepatocytes. The up-regulation of CAR mRNA and protein in response to dexamethasone explains the synergistic effect of this glucocorticoid on phenobarbital-mediated induction of CYP2B genes and the controversial role of the glucocorticoid receptor on phenobarbital-mediated CYP gene inductions.

1 August 2000 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
JPJean-Marc Pascussi
Jean-Marc Pascussi
SGsabine GERBAL-CHALOIN
sabine GERBAL-CHALOIN
LPLydiane Pichard-Garcia
Lydiane Pichard-Garcia
MDMartine Daujat-Chavanieu
Martine Daujat-Chavanieu
JFJean-Michel Fabre
Jean-Michel Fabre
MVMarie-José Vilarem
Marie-José Vilarem